Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
Charles Okyere Boadu, Medical Laboratory Science Student at the University for Development Studies, shared on LinkedIn:
”Donating blood may protect more than patients.
It could help lower the risk of stroke and organ damage in some donors.
We all know that donating blood saves lives for patients battling cancer, undergoing surgery, surviving trauma, or managing chronic illnesses.
But beyond saving others, blood donation can sometimes help save your own life too.
Many people rarely go for routine medical check ups unless they feel sick.
Yet every time you donate blood, you go through a mandatory screening process including a haemoglobin test.
This simple test works like a mini health check and can reveal important clues about your internal health.
For example, some people unknowingly live with Polycythemia Vera, a rare condition where the body produces too many red blood cells.
Most people with this condition has no early symptoms, so it can remain hidden for a long time.
During donor screening, an unusually high haemoglobin level can become an early warning sign.
The laboratory scientist can then prompt the donor to visit the hospital for further checks, monitoring, education, and treatment.
In people diagnosed with Polycythemia Vera, therapeutic venesection is often done to reduce the thickness of the blood and lower the risk of complications.
If this condition is not detected early, the blood can become too thick and lead to life threatening complications such as stroke, heart attack, and other cardiovascular problems.
Imagine walking in to donate blood to save a stranger and discovering a condition that was silently threatening your own future.
The lesson is simple. When you step forward to save a life through blood donation, you may also uncover hidden health conditions that help protect your own life.
Donate blood. Save lives and possibly your own too.”

Stay updated with Hemostasis Today.
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V JÖ‰ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem KhachatryanÖ‰ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC